DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • China
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
300896 logo

Imeik Technology Development Co.,Ltd. Stock Price

SZSE:300896 Community·CN¥26.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

300896 Share Price Performance

CN¥87.66
-107.25 (-55.03%)
​
CN¥87.66
-107.25 (-55.03%)
​
Price CN¥87.66
Sat, 12 Sep 26
Share Pricen/a

300896 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very undervalued with flawless balance sheet.

1 Risk
4 Rewards
View Full Analysis

Imeik Technology Development Co.,Ltd. Key Details

CN¥2.4b

Revenue

CN¥186.1m

Cost of Revenue

CN¥2.2b

Gross Profit

CN¥1.1b

Other Expenses

CN¥1.1b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
3.63
92.15%
46.22%
0%
View Full Analysis

About 300896

Founded
2004
Employees
1458
CEO
Yifeng Shi
WebsiteView website
www.imeik.net/cn/

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products. It serves medical aesthetic institutions. The company was incorporated in 2004 and is headquartered in Beijing, China.

Recent 300896 News & Updates

Recent updates

No updates

Imeik Technology Development Co.,Ltd. Competitors

603259 logo

WuXi AppTec

Symbol: SHSE:603259
Market cap: CN¥449.0b
600276 logo

Jiangsu Hengrui PharmaceuticalsLtd

Symbol: SHSE:600276
Market cap: CN¥281.1b
688506 logo

Sichuan Biokin PharmaceuticalLtd

Symbol: SHSE:688506
Market cap: CN¥98.5b
000538 logo

Yunnan Baiyao GroupLtd

Symbol: SZSE:000538
Market cap: CN¥89.9b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide